Center for Pulmonary and Infectious Disease Control, The University of Texas Health Science Center, Tyler, TX 75708, USA.
Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S114-8. doi: 10.1016/j.tube.2011.10.020. Epub 2011 Dec 9.
Although ESAT-6 was originally identified as a strong T cell immunogen in short-term culture filtrate of Mtb, and has therefore been a candidate vaccine antigen for many years, recent work has demonstrated that ESAT-6 is also a virulence factor that mediates pathogenicity of Mtb. The studies described in this review suggest that ESAT-6 secreted by Mtb subverts host immunity by manipulating intracellular signaling pathways in macrophages and T cells, which are critical in protection against Mtb. Furthermore, ESAT-6 elicits pro-inflammatory responses that can be detrimental to the host. Understanding the molecular mechanisms through which ESAT-6 inhibits immunity will permit design of ESAT-6-based vaccine constructs that elicit protective immune responses with minimal negative effects.
虽然 ESAT-6 最初被鉴定为 Mtb 短期培养滤液中的一种强 T 细胞免疫原,因此多年来一直是候选疫苗抗原,但最近的研究表明 ESAT-6 也是一种毒力因子,介导 Mtb 的致病性。本综述中描述的研究表明,Mtb 分泌的 ESAT-6 通过操纵巨噬细胞和 T 细胞中的细胞内信号通路来颠覆宿主免疫,这对抵抗 Mtb 至关重要。此外,ESAT-6 引发的促炎反应可能对宿主有害。了解 ESAT-6 抑制免疫的分子机制将允许设计基于 ESAT-6 的疫苗构建体,这些构建体引发具有最小负面影响的保护性免疫反应。